Detalhe da pesquisa
1.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Lancet
; 403(10432): 1153-1163, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461843
2.
Suprachoroidal Space Injection Technique: Expert Panel Guidance.
Retina
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451179
3.
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 130(6): 588-597, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754174
4.
PHASE 2 RANDOMIZED STUDY (ORION-1) OF A NOVEL, BIODEGRADABLE DEXAMETHASONE IMPLANT (AR-1105) FOR THE TREATMENT OF MACULAR EDEMA DUE TO CENTRAL OR BRANCH RETINAL VEIN OCCLUSION.
Retina
; 43(1): 25-33, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542081
5.
INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial.
Retina
; 42(6): 1111-1120, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35234673
6.
PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Retina
; 41(1): 144-155, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134802
7.
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
Ophthalmology
; 127(2): 186-195, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31474439
8.
SUPPLEMENTAL SCLERAL BUCKLE IN THE ERA OF SMALL INCISION VITRECTOMY AND WIDE-ANGLE VIEWING SYSTEMS.
Retina
; 40(10): 1894-1899, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31834132
9.
Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study).
Graefes Arch Clin Exp Ophthalmol
; 257(12): 2639-2653, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654188
10.
Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes.
Hum Mol Genet
; 24(16): 4491-503, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25964427
11.
Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
Ophthalmology
; 124(1): 74-81, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836430
12.
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.
Retina
; 37(5): 819-835, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27902638
13.
Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.
Neurobiol Dis
; 93: 64-77, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27109188
14.
Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions.
Hum Mol Genet
; 23(13): 3537-51, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24584571
15.
Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).
Ophthalmology
; 123(6): 1269-77, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26996339
16.
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
Ophthalmology
; 123(4): 850-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26832658
17.
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials.
Ophthalmology
; 123(7): 1511-20, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084563
18.
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
Ophthalmology
; 123(2): 330-336, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522708
19.
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Ophthalmology
; 123(11): 2376-2385, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27651226
20.
PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Retina
; 36(10): 1843-50, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27135213